Devil’s claw (Harpagophytum spp.) is a southern African medicinal plant with little documented traditional use which, nonetheless, has become a successful pharmaceutical commodity after being introduced to the German marketplace in the 1950s. From there it has evolved into a phytopharmaceutical for the treatment of pain caused by arthritis, rheumatism and inflammation. It remains underutilized in other parts of the world – perhaps due to its unappealing common name – but also in other applications with traditional use evidence, e.g. gastrointestinal complaints and veterinary medicine. This book summarizes its pathway to market, substantiates its efficacious and safe use, and also looks into aspects of stakeholder involvement and access-benefit sharing, given that it is largely harvested from wild populations. The book is aimed at researchers, healthcare professionals, students, and policy makers working in phytopharmacy and medicinal plants.
We ship worldwide - see checkout for options
Exceptional customer service trusted by 100's




Reviews
There are no reviews yet.